Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

GNW vs CNO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CNO Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–3 Matrix Metrics)

CNO Overall Winner 6-Pillar Tally: GNW 2 – 3 CNO (1 Tie) Matrix Metrics: GNW 3 – 7 CNO

As of Nov 19, 2026, CNO Financial Group, Inc. (CNO) is the stronger overall head-to-head candidate over Genworth Financial, Inc. (GNW) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). GNW carries a Unified Composite Score of 40.9/100 (SELL) at $7.69 (6.7x Forward P/E, 4.5% operating margin), whereas CNO carries 46.9/100 (HOLD) at $55.02 (10.7x Forward P/E, 16.9% operating margin).

  • Technical & Structure Timing Caution: GNW is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.2); meanwhile CNO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 44.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GNW vs CNO
GNW NYSE
Genworth Financial, Inc.
Life Insurance
$7.69
-2.29% 1D
Market Cap $2.9B
TTM Revenue $4.82B
Forward P/E 6.7x
Beta / 30D Vol 0.21β · 26% Vol
Unified Composite Score
40.9 / 100 SELL
Tech 23.0 Fund 38.0 Flow 50.0 Mom 49.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.9%), weak momentum, RSI 21
RSI-14: 21.2 · SMA20: $8.65 · SMA50: $9.15
CNO NYSE Head-to-Head Winner
CNO Financial Group, Inc.
Accident & Health Insurance
$55.02
-2.31% 1D
Market Cap $5.1B
TTM Revenue $4.54B
Forward P/E 10.7x
Beta / 30D Vol 0.30β · 28% Vol
Unified Composite Score
46.9 / 100 HOLD
Tech 45.0 Fund 48.0 Flow 50.0 Mom 46.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 44
RSI-14: 44.0 · SMA20: $56.39 · SMA50: $55.08

6-Pillar Scorecard Institutional Category Breakdown (GNW 2 – 3 CNO)

Columns: Metric · GNW · CNO
1. Valuation Multiples GNW
Forward P/E 6.7x 10.7x
Trailing P/E 78.7x 12.9x
PEG Ratio 0.31x 1.29x
EV / Revenue 0.6x 1.1x
2. Growth & Scale GNW
Revenue Growth (YoY) -7.1% -8.6%
Earnings Growth (YoY) +0.0% +615.1%
TTM Revenue (USD) $4.82B $4.54B
Market Cap $2.9B $5.1B
3. Profitability & Quality CNO
Gross Margin 4.5% 41.0%
Operating Margin 4.5% 16.9%
Net Profit Margin 0.8% 9.2%
Return on Equity (ROE) 1.7% 16.9%
4. Balance Sheet & Cash Flow CNO
Cash Generation (TTM) $142M EBITDA $1.08B EBITDA
Cash Flow Margin 3.0% EBITDA Mgn 23.8% EBITDA Mgn
Net Cash / Leverage $23.33 Book/Sh · 1.7% ROE $25.34 Book/Sh · 16.9% ROE
Dividend Yield None (0.00%) 1.24%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 34.0% (100th %ile) 23.4% (<1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CNO
OpEx & R&D Intensity N/A 24.1% of Rev ($1.10B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Insurance - Life Operator Insurance - Life Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GNW (3) vs CNO (7)
Institutional Metric GNW CNO Criterion Row Edge
Market Capitalization
Scale
$2.9B $5.1B Larger Scale CNO
Trailing P/E Ratio
Valuation
78.7x 12.9x Lower Multiple CNO
Forward P/E Ratio
Valuation
6.7x 10.7x Lower Multiple GNW
Revenue Growth (YoY)
Growth
-7.1% -8.6% Higher Growth GNW
Operating Margin (TTM)
Profitability
4.5% 16.9% Higher Margin CNO
Net Profit Margin
Profitability
0.8% 9.2% Higher Margin CNO
Return on Equity (ROE)
Capital Efficiency
1.7% 16.9% Higher ROE CNO
52-Week Range Position
Momentum
3% ($8–$11) 80% ($39–$59) Stronger Trend CNO
Beta / 30D Volatility
Risk Regime
0.21β · 26% Vol 0.30β · 28% Vol Lower Realized Risk GNW
Unified Institutional Score
Composite Signal
40.9 / 100 (SELL) 46.9 / 100 (HOLD) Higher Composite CNO
Trailing 12M Revenue (USD)
Operating Scale
$4.82B $4.54B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
4.5% 41.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.31x PEG · 0.6x EV/Rev 1.29x PEG · 1.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$142M EBITDA ($23.33 Book/Sh · 1.7% ROE) $1.08B EBITDA ($25.34 Book/Sh · 16.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CNO +12.41 pp
GNW: -13.11% · CNO: -0.7%
3M Horizon CNO +24.97 pp
GNW: -22.17% · CNO: +2.8%
6M Horizon CNO +32.98 pp
GNW: -16.86% · CNO: +16.12%
1Y Horizon CNO +45.73 pp
GNW: -8.56% · CNO: +37.17%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNW vs CNO. Trailing 12-month operating profitability (GNW 4.5% vs CNO 16.9%) and valuation multiples (GNW 6.7x vs CNO 10.7x Forward P/E) are benchmarked directly in Pillar 4 below.

GNW ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.82B
Gross Margin4.5%
Op. Margin4.5%
ROE / Fwd P/E1.7% · 6.7x
CNO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.54B
Gross Margin41.0%
Op. Margin16.9%
ROE / Fwd P/E16.9% · 10.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GNW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 34.0%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GNW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CNO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 23.4%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CNO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GNW Moat Profile Cyclical / Execution-Driven Positioning
Insurance - Life Operator
Competes within the Insurance - Life value chain with $2.9B market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CNO Moat Profile Scale & Operating Efficiency Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with $5.1B market capitalization and 16.9% operating margin.
OpEx & R&D Reinvestment 24.1% of Rev ($1.10B)
90D Engineering Disclosures 0 Published

Investor FAQ GNW vs CNO Key Questions & Quantitative Answers

As of Nov 19, 2026, CNO Financial Group, Inc. (CNO) is the stronger overall head-to-head candidate over Genworth Financial, Inc. (GNW) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). GNW carries a Unified Composite Score of 40.9/100 (SELL) at $7.69 (6.7x Forward P/E, 4.5% operating margin), whereas CNO carries 46.9/100 (HOLD) at $55.02 (10.7x Forward P/E, 16.9% operating margin). Technical & Structure Timing Caution: GNW is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.2); meanwhile CNO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 44.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GNW leads the Growth & Scale pillar: GNW posts -7.1% YoY revenue growth and +0.0% YoY earnings growth on $4.82B TTM revenue (4.5% gross margin, 4.5% operating margin), compared with CNO at -8.6% YoY revenue growth and +615.1% YoY earnings growth on $4.54B TTM revenue (41.0% gross margin, 16.9% operating margin). On trailing 12-month operating scale, GNW generates $4.82B in USD-normalized revenue versus $4.54B for CNO. In operating R&D and SG&A reinvestment, GNW deploys N/A (0 90-day corporate R&D disclosures) versus 24.1% of Rev ($1.10B) (0 disclosures) for CNO.

GNW screens cheaper on headline valuation multiples. GNW trades at 6.7x Forward P/E, 78.7x Trailing P/E, 0.31x PEG, and 0.6x EV/Revenue (3.0% EBITDA margin), whereas CNO trades at 10.7x Forward P/E, 12.9x Trailing P/E, 1.29x PEG, and 1.1x EV/Revenue (23.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GNW (1.7% ROE) versus CNO (16.9% ROE) capital efficiency.

In options market volatility and institutional positioning, GNW carries 34.0% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.21β · 26% Vol realized risk). By comparison, CNO carries 23.4% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.30β · 28% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.